SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Total Voting Rights

2 Sep 2024 07:00

RNS Number : 0542C
Cerillion PLC
02 September 2024
 

AIM: CER

Cerillion plc

("Cerillion" or the "Company")

Total Voting Rights

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, the Company's issued share capital as at 31 August 2024 consisted of 29,535,614 shares of 0.5 pence each in the Company ("Ordinary Shares"). All Ordinary Shares have voting rights.

 

There are no Ordinary Shares held in Treasury.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

Enquiries:

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Panmure Liberum Limited (Nomad and Joint Broker)

T: 020 3100 2000

Bidhi Bhoma, Edward Mansfield, Matthew Hogg

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management, with a 24-year track record in providing comprehensive revenue and customer management solutions. The Company has around 80 customers across 45 countries, principally serving the telecommunications market.

The Company is headquartered in London and also has operations in India (in Pune, Ahmedabad, and Indore), Bulgaria (in Sofia), Singapore, USA (in Boston) and Australia (in Sydney).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRQKFBDABKDAFB

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS